Basel Medical Group Stock Technical Analysis
| BMGL Stock | 0.77 0.04 4.98% |
As of the 29th of January, Basel Medical shows the Mean Deviation of 4.95, standard deviation of 7.1, and Risk Adjusted Performance of (0.08). Basel Medical Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Basel Medical Group information ratio and potential upside to decide if Basel Medical Group is priced correctly, providing market reflects its regular price of 0.7697 per share. As Basel Medical Group is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Basel Medical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Basel, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BaselBasel Medical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. Projected growth potential of Basel fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Basel Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.51) | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets | Return On Equity |
Investors evaluate Basel Medical Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Basel Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Basel Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Basel Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Basel Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Basel Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Basel Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Basel Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Basel Medical.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Basel Medical on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Basel Medical Group or generate 0.0% return on investment in Basel Medical over 90 days. Basel Medical is related to or competes with P3 Health, Vicarious Surgical, Longduoduo Company, Precipio, IBio Common, Nutriband, and Iterum Therapeutics. Basel Medical is entity of United States More
Basel Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Basel Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Basel Medical Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 42.69 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 12.31 |
Basel Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Basel Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Basel Medical's standard deviation. In reality, there are many statistical measures that can use Basel Medical historical prices to predict the future Basel Medical's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.45) | |||
| Treynor Ratio | (0.92) |
Basel Medical January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.91) | |||
| Mean Deviation | 4.95 | |||
| Coefficient Of Variation | (871.30) | |||
| Standard Deviation | 7.1 | |||
| Variance | 50.42 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.45) | |||
| Treynor Ratio | (0.92) | |||
| Maximum Drawdown | 42.69 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 12.31 | |||
| Skewness | 1.3 | |||
| Kurtosis | 4.79 |
Basel Medical Group Backtested Returns
Basel Medical Group secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Basel Medical Group exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Basel Medical's Mean Deviation of 4.95, risk adjusted performance of (0.08), and Standard Deviation of 7.1 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.9, which signifies possible diversification benefits within a given portfolio. Basel Medical returns are very sensitive to returns on the market. As the market goes up or down, Basel Medical is expected to follow. At this point, Basel Medical Group has a negative expected return of -0.78%. Please make sure to confirm Basel Medical's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Basel Medical Group performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.23 |
Weak reverse predictability
Basel Medical Group has weak reverse predictability. Overlapping area represents the amount of predictability between Basel Medical time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Basel Medical Group price movement. The serial correlation of -0.23 indicates that over 23.0% of current Basel Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Basel Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Basel Medical Group Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Basel Medical Group across different markets.
About Basel Medical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Basel Medical Group on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Basel Medical Group based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Basel Medical Group price pattern first instead of the macroeconomic environment surrounding Basel Medical Group. By analyzing Basel Medical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Basel Medical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Basel Medical specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2025 | 2026 (projected) | Days Sales Outstanding | 451.91 | 92.51 | 87.88 | PTB Ratio | 14.92 | 17.16 | 24.43 |
Basel Medical January 29, 2026 Technical Indicators
Most technical analysis of Basel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Basel from various momentum indicators to cycle indicators. When you analyze Basel charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.91) | |||
| Mean Deviation | 4.95 | |||
| Coefficient Of Variation | (871.30) | |||
| Standard Deviation | 7.1 | |||
| Variance | 50.42 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.45) | |||
| Treynor Ratio | (0.92) | |||
| Maximum Drawdown | 42.69 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 12.31 | |||
| Skewness | 1.3 | |||
| Kurtosis | 4.79 |
Basel Medical January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Basel stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.11 | ||
| Daily Balance Of Power | (0.45) | ||
| Rate Of Daily Change | 0.95 | ||
| Day Median Price | 0.77 | ||
| Day Typical Price | 0.77 | ||
| Price Action Indicator | (0.02) | ||
| Market Facilitation Index | 0.09 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Basel Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. Projected growth potential of Basel fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Basel Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.51) | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets | Return On Equity |
Investors evaluate Basel Medical Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Basel Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Basel Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Basel Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Basel Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Basel Medical's market price signifies the transaction level at which participants voluntarily complete trades.